CRISPR/Cas9-engineering of HMC-1.2 cells renders a human mast cell line with a single D816V-KIT mutation: An improved preclinical model for research on mastocytosis.
Frontiers In Immunology
Bandara, Geethani G; Falduto, Guido H GH; Luker, Andrea A; Bai, Yun Y; Pfeiffer, Annika A; Lack, Justin J; Metcalfe, Dean D DD; Olivera, Ana A
Calibration of computational tools for missense variant pathogenicity classification and ClinGen recommendations for PP3/BP4 criteria.
American Journal Of Human Genetics
Pejaver, Vikas V; Byrne, Alicia B AB; Feng, Bing-Jian BJ; Pagel, Kymberleigh A KA; Mooney, Sean D SD; Karchin, Rachel R; O'Donnell-Luria, Anne A; Harrison, Steven M SM; Tavtigian, Sean V SV; Greenblatt, Marc S MS; Biesecker, Leslie G LG; Radivojac, Predrag P; Brenner, Steven E SE; ,
Publication Date: 2022-12-01
Variant appearance in text: KIT: Y568F; rs749851557
Activating c-KIT mutations confer oncogenic cooperativity and rescue RUNX1/ETO-induced DNA damage and apoptosis in human primary CD34+ hematopoietic progenitors.
Leukemia
Wichmann, C C; Quagliano-Lo Coco, I I; Yildiz, Ö Ö; Chen-Wichmann, L L; Weber, H H; Syzonenko, T T; Döring, C C; Brendel, C C; Ponnusamy, K K; Kinner, A A; Brandts, C C; Henschler, R R; Grez, M M
Direct binding of Cbl to Tyr568 and Tyr936 of the stem cell factor receptor/c-Kit is required for ligand-induced ubiquitination, internalization and degradation.
The Biochemical Journal
Masson, Kristina K; Heiss, Elke E; Band, Hamid H; Rönnstrand, Lars L